Significance of genotype in tetrahydrobiopterin-responsive phenylketonuria
- 340 Downloads
The value of genotyping to identify tetrahydrobiopterin-responsive (BH4-responsive) patients with phenylalanine hydroxylase (PAH) deficiency is a matter of debate.
We reviewed 250 cases of patients with PAH deficiency, using published data from 198 cases and unpublished data from 52 cases of patients attending our own clinic. Patients underwent analyses for BH4 load and genetic mutations. Partial and full BH4 responses were defined as a 10–29% decrease and a ≥30% decrease from baseline in blood phenylalanine levels, respectively. BH4-responsive alleles were identified from BH4-responsive patients as either homozygous for a specific allele or compound heterozygous for that allele with a null mutation.
Most inconsistencies between observed genotype and BH4 response were associated with mutations in the regulatory domain of PAH (p.R68S, p.I65T, p.L48S and p.F39C), where 20/62 alleles (32.2%) were non-responsive. In the catalytic domain (mutations p.Y414C, p.R261Q, p.E390G, p.A300S, p.R241C, p.A403V and p.V388M), only 8/125 alleles (6.4%) were non-responsive. Seven patients had a genotype with two BH4-responsive alleles resulting in no response or only a partial response to BH4. Ten patients had identical genotypes but inconsistent responses in BH4 load.
These results show that BH4 non-responsiveness is associated with genotype. However, patients with mutations in the regulatory domain show inconsistent results. In patients with two responsive alleles, non-responsiveness may be related to negative inter-allelic complementation. In patients with the same genotype and inconsistent results for BH4 load, external factors such as intestinal absorption of BH4, catabolic conditions or other genetic factors may be responsible. Further in vitro studies are necessary to clarify the genotype–phenotype correlation in patients with BH4-responsive PKU.
- Kaufman S (1976) Phenylketonuria: biochemical mechanisms. Adv Neurochem 2: 1–132.Google Scholar
- Levy HL, Milanowski A, Chakrapani A, et al (2007a) Sapropterin Research Group. Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled study. Lancet 370: 504–510. doi:10.1016/S0140-6736(07)61234-3.PubMedCrossRefGoogle Scholar
- Martinez MA. PAH as misfolding disease. International Conference on tetrahydrobiopterin, PKU and NOS. March 23–28 2008, St. Moritz-Champfer, Switzerland. Google Scholar
- Scriver CR, Kaufman S (2001) Hyperphenylalaninemia: phenylalanine hydroxylase deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 1667–1724.Google Scholar